Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy

• Status: Completed
• Trial end date: 2016-12-30
• Target enrollment: 0
• Participant gender: All

Summary

The Atkins Diet Modified (ADM) is the best alternative treatment for drug-resistant epilepsy, There is a high prevalence worldwide , especially in Latin American countries, including Mexico.

Low income earners, many of which do not have a social security, must meet the high costs by Antiepileptic Drugs (AEDS), which in addition should be used in conjunction or combination therapy, because monotherapy is insufficient .

The diet adkins makes some changes in the traditional food habits by others that are accessible and not necessarily expensive, whose mechanism allows for better control of the seizures.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Instituto Mexicano del Seguro Social
• Treatments: Anticonvulsants

Criteria

Inclusion Criteria:

• Minimum age of 18 years

• Patients that meet the criteria of drug-resistant epilepsy

• Patients treated with Rational polytherapy, a minimum of 6 months, with no changes in their drug refractory condition.

• Patients with drug- resistant epilepsy with informed consent signed by themselves and their proxy.

• Patients with drug-resistant epilepsy of any etiology, except tumor, metabolic, degenerative or progressive.

Exclusion Criteria:

• Patients with drug-resistant epilepsy simultaneous alternate treatment to the Atkins Diet modified.

• Patients with a neurological entity progressive and fatal

• Patients with congenital diseases and difficulty to metabolize fats or that require high amounts of carbohydrates in the diet.